M&A

Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer

Novo Holdings A/S

COVID-19 Vaccine

Pfizer and BioNTech to Vaccinate Olympic Athletes in Tokyo

Pfizer

Emergency Use

Pfizer and BioNtech Receive First U.S. Authorization for Emergency Use of Covid-19 Vaccine in Adolescents

Pfizer

COVID-19

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study

Pfizer

COVID-19 Vaccine

Pfizer and BioNTech Announce Data from Preclinical Studies of COVID-19 Vaccine Candidate

Pfizer

Agreement

PPD Signs New Service Agreement with Pfizer

PPD, part of Thermo Fisher Scientific

COVID-19 Vaccine

Pfizer and BioNTech to Receive $2 Billion from U.S. Government

Pfizer

COVID-19 Vaccine

Pfizer and BioNTech Report T Cell Response in COVID-19 Vaccine

Pfizer

COVID-19 Vaccine

Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2

Pfizer

Investment

Pfizer Establishes New Program to Support Continued Biotechnology Innovation

Pfizer

Medical Professionals Across Merck, Pfizer, and Eli Lilly Volunteer Amid COVID-19 Pandemic

Eli Lilly and Company

M&A

Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn

Mylan

Vaccine

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

BioNTech

Artificial Intelligence

Insilico Enters into Artificial Intelligence Collaboration with Pfizer

Insilico Medicine

Licensing Agreement

Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX

Pfizer

Leadership

Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman

Pfizer

Vaccine

Pfizer Announces Positive Preliminary Results from a 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate for Disease Prevention in Infants

Pfizer

Investment

The Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance

The Pfizer Foundation

Recall

Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® Due to Potential Microbiological Contamination of Non-Sterile Product

Pfizer